Half of US Parents of Teens Got Their Child Vaccinated, but Uptake Slows
Nearly half of 12- to 17-year-olds in the United States have had at least one COVID-19 vaccine shot, but the initial rush to get teens immunized has stalled.
Nearly half of 12- to 17-year-olds in the United States have had at least one COVID-19 vaccine shot, but the initial rush to get teens immunized has stalled.
In this Q&A, Erica Johnson, MD, provides insight into the new oral antiviral medications that may soon be approved for the treatment of COVID-19.
US pharmacies are struggling to keep up with Americans’ demand for COVID-19 vaccines and tests, and the pressure could intensify as antiviral pills to treat COVID-19 are approved by federal regulators.
The independent study conducted by Dan Barouch, MD, PhD, et al of Beth Israel Deaconess Medical Center included a subset of participants from the COV2008 study.
The expanded authorization was based on data from the phase 2/3 BLAZE-1 trial.
The vaccine effectiveness of two doses of Moderna mRNA-1273 is 87.4% against COVID-19 infection and 95.8 and 97.9% against COVID-19 hospitalization and hospital death, respectively.
Most cases of suspected COVID-19 vaccine-related myocarditis occurring in young people have a mild clinical course.
Most vaccinated American adults have every intention of getting booster shots.
BNT162b2 elicits relatively lower antibody levels to the SARS-CoV-2 spike receptor binding domain than mRNA-1273, and lower antibody levels are observed with BNT162b2 in older versus younger adults.
In 2020, there were increases in the incidence of health care-associated infection.